Ali Ahmadi

Ali Ahmadi

Auto-generated profile, based on publicly available information

Ali Ahmadi

Department of Medical Parasitology and Mycology, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in Hemoglobin
Verified
Journal Article
Closed access
ZRZohreh Rahimi
Zohreh Rahimi
RAReza Akramipour
Reza Akramipour
RNRonald L. Nagel
Ronald L. Nagel
AAAli S. Ahmadi
Ali S. Ahmadi
AMAhmad Merat
Ahmad Merat
FBFariborz Bahrehmand
Fariborz Bahrehmand
Hb D-Los Angeles is characterized by the substitution of glutamine for glutamic acid at position 121 of the β-globin chain. The present investigation is the first study on the β-globin gene haplotypes associated with β-D-Los Angeles in Western Iran. Thirty two individuals from 11 unrelated families from Western Iran were studied. The Hb D-Los Angeles status of all cases was confirmed using polymerase chain reaction (PCR) followed by digestion with EcoRI. The haplotype of the β‐globin gene cluster was determined by a PCR-RFLP (restriction fragment length polymorphism) procedure. The haplotype background of the βA chromosomes was also determined in 35 normal subjects from the same geographic region. The β-globin gene haplotype analysis demonstrated that all β-D-Los Angeles genes (23 genes) were in linkage disequilibrium with haplotype I [+−−−−++]. Among the 70 βA chromosomes, 30 chromosomes (42.9%) were associated with haplotype I. The present study indicates the unicentric origin of the β-D-Los Angeles gene in Western Iran. It seems that this mutation may have occurred at the same chromosomal background common in the local population.

5 September 2021 in Journal of Environmental Health Science and Engineering
Verified
Journal Article
Closed access
PDF file
ARArash Rahimi
Arash Rahimi
ESElahe Sasani
Elahe Sasani
SRSassan Rezaie
Sassan Rezaie
MDMohammad Mehdi Soltan Dallal
Mohammad Mehdi Soltan Dallal
SMShahram Mahmoudi
Shahram Mahmoudi
SKSadegh Khodavaisy
Sadegh Khodavaisy

1 June 2020 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
AAAli Ahmadi
Ali Ahmadi
SMShahram Mahmoudi
Shahram Mahmoudi
SRSassan Rezaie
Sassan Rezaie
SHSayed Jamal Hashemi
Sayed Jamal Hashemi
Eric DannaouiEric Dannaoui
Eric Dannaoui
SKSadegh Khodavaisy
Sadegh Khodavaisy
Candida parapsilosis is a common non-albicans Candida species ranked as the second common cause of bloodstream infections. Azole resistance and elevated echinocandin minimum inhibitory concentrations have been reported for these fungi. This study was conducted to determine the interactions between azoles and echinocandins against C. parapsilosis species complex. Fifteen fluconazole-resistant clinical isolates of C. parapsilosis complex including C. parapsilosis (n = 7), C. orthopsilosis (n = 5), and C. metapsilosis (n = 3) were included. The activity of azoles (fluconazole, itraconazole) and echinocandins (anidulafungin, micafungin) alone and in combination was determined using checkerboard broth microdilution and results were determined based on fractional inhibitory concentration index (FICI). In vitro combination of fluconazole with anidulafungin was found synergistic (FICI: 0.07-0.37) and decreased the minimum inhibitory concentration (MIC) range from 4-64 µg/ml to 0.5-16 µg/ml for fluconazole and from 2-8 µg/ml to 0.125-1 µg/ml for anidulafungin. Similarly, interactions of fluconazole with micafungin (FICI: 0.25-0.5), itraconazole with anidulafungin (FICI: 0.15-0.37) and itraconazole with micafungin (FICI: 0.09-0.37) were synergistic. The combination of fluconazole and itraconazole with either anidulafungin or micafungin demonstrates synergistic interactions against C. parapsilosis species complex, especially against isolates with elevated MIC values. However, the use of these combinations in clinical practice and the clinical relevance of in vitro combination results remains unclear.

30 June 2025 in The Journal of Infection in Developing Countries
Verified
Journal Article
Open access
PDF file
MSMinoosh Shabani
Minoosh Shabani
BBBahareh Bashardoust
Bahareh Bashardoust
ABAleksandra Barac
Aleksandra Barac
JXJianping Xu
Jianping Xu
LALaura Alcazar-Fuoli
Laura Alcazar-Fuoli
SKSadegh Khodavaisy
Sadegh Khodavaisy
Introduction: Cryptococcal meningitis (CM) typically affects immunocompromised individuals and are commonly caused by Cryptococcus neoformans. Case Report: We present CM case involving an immunocompetent male due to Cryptococcus gattii molecular type VGI. Results: This case illustrates the diagnostic and management challenges associated with CM and emphasizes the need for continued vigilance in monitoring and understanding the epidemiology of cryptococcal infections in diverse patient populations. Conclusions: Our case highlights the significant morbidity associated with cryptococcosis.

19 October 2021 in Journal of Environmental Health Science and Engineering
Verified
Journal Article
Closed access
PDF file
ARArash Rahimi
Arash Rahimi
ESElahe Sasani
Elahe Sasani
SRSassan Rezaie
Sassan Rezaie
MDMohammad Mehdi Soltan Dallal
Mohammad Mehdi Soltan Dallal
SMShahram Mahmoudi
Shahram Mahmoudi
SKSadegh Khodavaisy
Sadegh Khodavaisy

1 January 2025 in Case Reports in Infectious Diseases
Verified
Journal Article
Open access
MHMarjan Hemmatian
Marjan Hemmatian
SKSadegh Khodavaisy
Sadegh Khodavaisy
HKHossein Kazemizadeh
Hossein Kazemizadeh
BJBehnaz Jahanbin
Behnaz Jahanbin
REReza Ershadi
Reza Ershadi
SMSeyed Ali Dehghan Manshadi
Seyed Ali Dehghan Manshadi
Opportunistic fungal infections (OFIs) are common among human immunodeficiency virus (HIV) –positive patients, especially in those with delayed diagnosis and treatment. Patients with severe HIV/AIDS with clusters of differentiation 4 (CD4) counts less than 100 are significantly prone to develop multiple OFIs. In the current study, we present a case of co‐infection of pulmonary aspergillosis and cryptococcal meningitis in a late‐diagnosed HIV patient with a low CD4 count.